For science parks
For companies
For talent
Internship opportunity for Clinical Pharmacology/Clinical Science Student Sherwood Pharmaceuticals
About the vacancy
Rare & Orphan Diseases
About Your Next Job
Sherwood Pharmaceuticals is a young startup exploring the first-ever treatment for Cri du Chat syndrome, a rare genetic disease. At Sherwood Pharmaceuticals we are assessing a drug repurposing opportunity for the potential treatment of Cri du Chat syndrome (CdCS) (a.k.a. 5p Monosomy). This rare disease affects 1:20,000 births but currently there are no dedicated treatments available. Get involved with an ambitious company working closely alongside an experienced founder team, knowledgeable patent attorneys and ongoing collaboration with academic partners and patient advocacy foundations.
This clinical pharmacology internship is an exciting opportunity for someone motivated to drive therapies into the hands of patients and their families as quickly as possible. Working closely with the CEO and Chief Development Officer to gain perspectives on the process of drug development – from bench to bedside. You will report to the Chief Development Officer.
The duration of the internship is 9 months.
What you will do:
- Learn to inventorize relevant data/reports available and thus assist in establishing selection criteria for short-listing of compounds most suitable to CdCS patients.
- Systematically evaluate shortlisted compounds e.g., based on clinical study reports (including pharmacokinetics and outcome measures) for adults and pediatrics
- Conduct initial formulation feasibility review based on literature, and interview experts in the field
- Deliverables: a comparison report for compound prioritization
- Work closely with the academic collaboration partner
- Attend relevant events and conferences, and be a full member of the team!
Your profile:
- Master’s degree student in clinical pharmacology/clinical sciences
- Affinity for neurosciences
- Comfortable working in a hybrid environment and in an international setting
- Self-driven, organized and enthusiastic
The offer:
- Full-time for 9 months, starting 1 October 2026
- Monthly student stipend of EUR 600
- Opportunity to make an impact on the quality of life for Cri du Chat patients and their families
About Your Next Colleagues
Get involved with an ambitious company working closely alongside an experienced founder team, knowledgeable patent attorneys and ongoing collaboration with academic partners and patient advocacy foundations.
About Your Tasks and Responsibilities
The duration of the internship is 9 months.
What you will do:
- Learn to inventorize relevant data/reports available and thus assist in establishing selection criteria for short-listing of compounds most suitable to CdCS patients.
- Systematically evaluate shortlisted compounds e.g., based on clinical study reports (including pharmacokinetics and outcome measures) for adults and pediatrics
- Conduct initial formulation feasibility review based on literature, and interview experts in the field
- Deliverables: a comparison report for compound prioritization
- Work closely with the academic collaboration partner
- Attend relevant events and conferences, and be a full member of the team!
About Your Skills and Experience
Your profile:
- Master’s degree student in clinical pharmacology/clinical sciences
- Affinity for neurosciences
- Comfortable working in a hybrid environment and in an international setting
- Self-driven, organized and enthusiastic
About Your Benefits
- Hybrid setting
- International team
- Learn from expert
Only apply if...
Only for serious applicants.
You are eligible to work in EU
We only accept applicants who are eligible to work in the EU
Contact person
Irisa Ono
No video available
Sherwood Pharmaceuticals is a young startup exploring the first-ever treatment for Cri du Chat syndrome, a rare genetic disease. At Sherwood Pharmaceuticals we are assessing a drug repurposing opportunity for the potential treatment of Cri du Chat syndrome (CdCS) (a.k.a. 5p Monosomy). This rare disease affects 1:20,000 births but currently there are no dedicated treatments available. Get involved with an ambitious company working closely alongside an experienced founder team, knowledgeable patent attorneys and ongoing collaboration with academic partners and patient advocacy foundations.